FTCYinactive

GLOBAL FUTURE CITY HOLDING INC.

Healthcare·Cardiovascular·Commercial
Cardiovascular

GLOBAL FUTURE CITY HOLDING INC. (FTCY): 161 pipeline candidates · ~3 mo cash runway. Updated within the last hour.

7.0/10

BioSniper Score

3-factor signal · derived from public data

Cash Runway0.9

3.2 months

Financial Health10.0

D/E -1.48 · 0% dilution

Pipeline MaturityN/A

N/A

Pipeline Breadth10.0

161 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for GLOBAL FUTURE CITY HOLDING INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

Cash

$773

Quarterly Burn

$166K

Runway

3.2 mo

Revenue

$2K

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Sep 2026
Today~7 mo out
Catalyst within runway

Pipeline (161 candidates)

Showing 10 of 161 candidates. Sign up for full pipeline.

Frequently asked questions

How many drug candidates are in GLOBAL FUTURE CITY HOLDING INC.'s pipeline?

GLOBAL FUTURE CITY HOLDING INC. (FTCY) has 161 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is GLOBAL FUTURE CITY HOLDING INC.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, GLOBAL FUTURE CITY HOLDING INC. has approximately 3.2 months of cash runway.

Get the full picture on GLOBAL FUTURE CITY HOLDING INC.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.